Amphastar Pharmaceuticals Inc.
Date Sent
File
Warning Letter to Amphastar Pharmaceuticals Inc.
(173.09 KB)
Displaying 21 - 40 of 1585
FTC Renews Challenge of More Than 200 Improper Patent Listings
Date
Continuing its efforts to promote competition and lower drug prices, today the Federal Trade Commission renewed its challenges against dozens of improperly listed device patents that shield brand-name...
Novartis Pharmaceuticals Corp.
Date Sent
File
Warning Letter to Novartis Pharmaceuticals Corp.
(175.19 KB)
FTC Approves Final Order with Welsh Carson
Date
The Federal Trade Commission finalized a consent order with Welsh, Carson, Anderson & Stowe and its affiliates (collectively referred to as Welsh Carson) that resolves a potential administrative...
Welsh, Carson, Anderson & Stowe, In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
201 0031
Case Status
Pending
Illinois and Minnesota Join FTC Lawsuit Challenging Medical Device Coatings Deal
Date
The Federal Trade Commission filed an amended complaint adding the states of Illinois and Minnesota as co-plaintiffs in the Commission’s lawsuit challenging GTCR BC Holdings, LLC’s (GTCR) acquisition...
B4B Corp.
The Federal Trade Commission, jointly with the Department of Justice and the U.S. Food and Drug Administration, have sued a New York-based marketer of herbal tea, seeking to permanently block deceptive ads that claim its Earth Tea is clinically proven to treat, cure, and prevent COVID-19.
Type of Action
Federal
Last Updated
FTC Matter/File Number
2223007
Case Status
Closed
FTC Staff Reaffirm Opposition to Proposed Indiana Hospital Merger
Date
Today, Federal Trade Commission staff again urged the Indiana Department of Health to deny Union Hospital, Inc. (Union Health) and Terre Haute Regional Hospital, L.P.’s (THRH) application to merge...
FTC Challenges Medical Device Coatings Deal
Date
The Federal Trade Commission today sued to block GTCR BC Holdings, LLC’s (GTCR) acquisition of Surmodics, Inc. (Surmodics), alleging that the deal, which seeks to combine the two largest manufacturers...
Federal Register Notice
Welsh, Carson, Anderson & Stowe; Analysis of Agreement Containing Consent Order To Aid Public Comment
Date
Statement of Chair Lina M. Khan In the Matter of Caremark/ESI/Optum
Date
By
Lina M. Khan, Former Chair and Commissioner
Matter Number
241 0005
File
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak In the Matter of US Anesthesia Partners/Guardian Anesthesia
Date
By
Andrew N. Ferguson, Chairman;
Melissa Holyoak, Commissioner
Matter Number
201 0031
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya In the Matter of Welsh, Carson, Anderson & Stowe
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
FTC Secures Settlement with Private Equity Firm in Antitrust Roll-Up Scheme Case
Date
The Federal Trade Commission today announced a settlement with private equity firm Welsh, Carson, Anderson, and Stowe and its affiliates (collectively referred to as “Welsh Carson”) that resolves a...
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak Regarding the Second Pharmacy Benefit Managers Interim Staff Report
Date
By
Andrew N. Ferguson, Chairman;
Melissa Holyoak, Commissioner
Matter Number
P221200
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
Date
The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty...
FTC Announces Tentative Agenda for January 14 Open Commission Meeting
Date
Today, Federal Trade Commission Chair Lina M. Khan announced that an open meeting of the Commission will be held virtually on Tuesday, January 14, 2025. The open meeting will commence at 11 a.m. ET...
Displaying 21 - 40 of 1585